Refoxy Pharma

Refoxy Pharma is a preclinical biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases. Refoxy's discovery platform, F.act finder (FOXO activator finder), provides molecules that specifically modulate FOXO3 and elicit unique therapeutic effects. The company is developing a range of treatments, initially focusing on fibrotic diseases.